This panel explored the impact of COVID-19 on AMR as well as promising new approaches to address AMR such as wastewater surveillance, genomic sequencing, and phages research.

Moderator:
-Rachel Roubein, National health-care reporter and author of The Health 202, The Washington Post
Speakers:
-Michael Craig, MPP, Director, Antimicrobial Resistance Coordination and Strategy Unit, CDC
-Amy Mathers, MD, D(ABMM), Associate Professor of Medicine and Pathology, University of Virginia School of Medicine Division of Infectious Diseases & International Health
-Jeff F. Miller, PhD, Fred Kavli Chair, NanoSystems Sciences; Director, California NanoSystems Institute; Professor, Dept. of Microbiology, Immunology and Molecular Genetics, UCLA
-Michael Ybarra, MD, FACEP, FAPC, Vice President of Advocacy and Strategic Alliances and Chief of Medical Affairs, PhRMA

свернуть